Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Polatuzumab Biosimilar – Anti-CD79B(CD79b, B29, IGB, Ig-beta) mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Polatuzumab Biosimilar - Anti-CD79B(CD79b, B29, IGB, Ig-beta) mAb - Research Grade |
|---|---|
| Source | DrugBank DB12240 |
| Species | Humanized |
| Molecular weight | 150kDa |
| Purity | >85% |
| Buffer | PBS buffer pH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Polatuzumab,,CD79B(CD79b, B29, IGB, Ig-beta),anti-CD79B(CD79b, B29, IGB, Ig-beta) |
| Reference | PX-TA1317 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Polatuzumab Biosimilar - Anti-CD79B(CD79b, B29, IGB, Ig-beta) mAb - Research Grade
General information on Anti-CD79B(CD79b, B29, IGB, Ig-beta)[Homo sapiens] (Polatuzumab) Monoclonal Antibody
Polatuzumab is a humanized IgG1, kappa antibody targetting human CD79B. This antigen is required in the initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR).
Related products
Antigen
Human CD79β-CD79B recombinant protein
PX-P6103 500$
Isotype Control
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
PTX17885 215$
ELISA
Polatuzumab ELISA Kit
KPTX229 1404$Contact us
Send us a message from the form below
Reviews
There are no reviews yet.